Prevalence of Dementia and Subtypes in Valladolid, Northwestern Spain: The DEMINVALL Study

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Tola Arribas, Miguel Angel ^a   Yugueros, María Isabel ^a   Garea, María José ^a   Ortega Valín, Fernando ^a   Cerón Fernández, Ana ^a   Fernández Malvido, Beatriz ^a   San José Gallegos, Antonio ^b   González Touya, Marta ^b   Botrán Velicia, Ana ^c   Iglesias Rodríguez, Vanessa ^c   Díaz Gómez, Bárbara ^d  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^b Hospital de Medina del Campo   (Spain)

^c Atención Primaria Valladolid Oeste   (Spain)

^d Alcobendas   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; MEMANTINE;

AGE; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMENTIA; DIFFUSE LEWY BODY DISEASE; EDUCATIONAL STATUS; FEMALE; FRONTOTEMPORAL DEMENTIA; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; PARKINSON DISEASE ASSOCIATED DEMENTIA; POPULATION RESEARCH; PREVALENCE; SECONDARY DEMENTIA; SPAIN; URBAN RURAL DIFFERENCE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SOCIOECONOMIC FACTORS; SPAIN;

EID: 84885817412     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077688     Document Type: Article

References (47)

1. Office for official Publications of the European Comunities (2012) The 2012 Ageing Report: Economic and budgetary projections for the; EU 27 Member States (2010- 2060). Luxembourg. Available: http://ec.europa.eu/economy_finance/publications/european_economy/2012/pdf/ee-2012-2_en.pdf. Accessed 2 June 2013.
2. World Health Organization (2013) The European health report 2012: Charting the way to well-being. Geneve. Available: http://www.euro.who.int/__data/assets/pdf_file/0003/184161/The-European-Health-Report-2012,-FULL-REPORT-w-cover.pdf. Accessed 2 June 2013.
3. Rechel B, Grundy E, Robine JM, Cylus J, Mackenbach JP, et al. (2013) Ageing in the European Union. Lancet 381: 1312-1322. doi:10.1016/S0140-6736(12)62087-X. PubMed: 23541057.
4. Wimo A, Jönsson L, Bond J, Prince M, Winblad B, et al. (2013) The worldwide economic impact of dementia 2010. Alzheimers Dement 9: 1-11. doi:10.1016/j.jalz.2013.01.002. PubMed: 23305821.
5. Prince M, Bryce R, Albanese E, Wimo A, Ribeiro W, et al. (2013) The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 9: 63-75. doi:10.1016/j.jalz.2012.11.007. PubMed: 23305823.
6. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, et al. (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366: 2112-2117. PubMed: 16360788.
7. Norton S, Matthews FE, Brayne C, (2013) A commentary on studies presenting projections of the future prevalence of dementia. BMC Public Health 13: 1. doi:10.1186/1471-2458-13-S3-S1. PubMed: 23280303.
8. Barnes DE, Yaffe K, (2011) The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol 10: 819-828. doi:10.1016/S1474-4422(11)70072-2. PubMed: 21775213.
9. Corrada M, Brookmeyer R, Kawas C, (1995) Sources of variability in prevalence rates of Alzheimer's disease. Int J Epidemiol 24: 1000-1005. doi:10.1093/ije/24.5.1000. PubMed: 8557432.
10. de Pedro-Cuesta J, Virués-Ortega J, Vega S, Seijo-Martínez M, Saz P, et al. (2009) Prevalence of dementia and major dementia subtypes in Spanish populations: a reanalysis of dementia prevalence surveys, 1990-2008. BMC Neurol 9: 55. doi:10.1186/1471-2377-9-55. PubMed: 19840375.
11. Gavrila D, Antúnez C, Tormo MJ, Carles R, García Santos JM, et al. (2009) Prevalence of dementia and cognitive impairment in Southeastern Spain: the Ariadna study. Acta Neurol Scand 120: 300-307. doi:10.1111/j.1600-0404.2009.01283.x. PubMed: 19832772.
12. Gascón-Bayarri J, Reñé R, Del Barrio JL, De Pedro-Cuesta J, Ramón JM, et al. (2007) Prevalence of dementia subtypes in El Prat de Llobregat, Catalonia, Spain: the PRATICON study. Neuroepidemiology 28: 224-234. doi:10.1159/000108597. PubMed: 17878737.
13. Fernández M, Castro-Flores J, Perez-de las Heras S, Mandaluniz-Lekumberri A, Gordejuela M, et al. (2008) Prevalence of dementia in the elderly aged above 65 in a district in the Basque Country. Rev Neurol 46: 89-96. PubMed: 18247280.
14. Virues-Ortega J, de Pedro-Cuesta J, Vega S, Seijo-Martinez M, Saz P, et al. (2010) Prevalence and European comparison of dementia in a >/=75-year-old composite population in Spain. Acta Neurol Scand 123: 316-324.
15. Tola-Arribas MA, Garea MJ, Yugueros MI, Ortega-Valin F, Ceron A,et al (2012) Design, methods and demographic findings of the DEMINVALL survey: a population-based study of Dementia in Valladolid, Northwestern Spain. BMC Neurol 12: 86. doi:10.1186/1471-2377-12-86. PubMed: 22935626.
16. Solomon PR, Hirschoff A, Kelly B, Relin M, Brush M, et al. (1998) A 7 minute neurocognitive screening battery highly sensitive to Alzheimer's disease. Arch Neurol 55: 349-355. doi:10.1001/archneur.55.3.349. PubMed: 9520009.
17. del Ser Quijano T, Sanchez Sanchez F, Garcia de Yebenes MJ, Otero Puime A, Zunzunegui MV, et al. (2004) Spanish version of the 7 Minute screening neurocognitive battery. Normative Data An Elderly Populations Sample Over 70. Neurologia 19: 344-358.
18. del Ser T, Sánchez-Sánchez F, García de Yébenes MJ, Otero A, Munoz DG, (2006) Validation of the seven-minute screen neurocognitive battery for the diagnosis of dementia in a Spanish population-based sample. Dement Geriatr Cogn Disord 22: 454-464. doi:10.1159/000095858. PubMed: 16988506.
19. Jorm AF, Korten AE, (1988) Assessment of cognitive decline in the elderly by informant interview. Br J Psychiatry 152: 209-213. doi:10.1192/bjp.152.2.209. PubMed: 3167337.
20. Kawas C, Segal J, Stewart WF, Corrada M, Thal LJ, (1994) A validation study of the Dementia Questionnaire. Arch Neurol 51: 901-906. doi:10.1001/archneur.1994.00540210073015. PubMed: 8080390.
21. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, et al. (1986) CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry 149: 698-709. doi:10.1192/bjp.149.6.698. PubMed: 3790869.
22. Linn MW, Linn BS, (1982) The rapid disability rating scale-2. J Am Geriatr Soc 30: 378-382. PubMed: 7077018.
23. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL, (1982) A new clinical scale for the staging of dementia. Br J Psychiatry 140: 566-572. doi:10.1192/bjp.140.6.566. PubMed: 7104545.
24. American Psychiatric Association (1994) Diagnostic and Statistical Manual of Mental Disorders. 4th edn. DSM-IV. Washington DC. pp pp. 133-155.
25. McKhann G, Drachman D, Folstein M, Katzman R, Price D, et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34: 939-944. doi:10.1212/WNL.34.7.939. PubMed: 6610841.
26. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43: 250-260. doi:10.1212/WNL.43.2.250. PubMed: 8094895.
27. Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, et al. (1998) Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554. doi:10.1212/WNL.51.6.1546. PubMed: 9855500.
28. McKeith IG, (2006) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis 9: 417-423. PubMed: 16914880.
29. Reynish E, Fratiglioni L, Prince M, Bickel H, Kiejna A, et al. (2006) EUROCODE: Report of WP7 2006. Prevalence of dementia in Europe Alzheimer Europe. Available: http://ec.europa.eu/health/archive/ph_information/dissemination/diseases/docs/eurocode.pdf. Accessed 2 June 2013.
30. Kalaria RN, Maestre GE, Arizaga R, Friedland RP, Galasko D, et al. (2008) Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors. Lancet Neurol 7: 812-826. doi:10.1016/S1474-4422(08)70169-8. PubMed: 18667359.
31. Benedetti MD, Salviati A, Filipponi S, Manfredi M, De Togni L, et al. (2002) Prevalence of dementia and Apolipoprotein E genotype distribution in the elderly of Buttapietra, Verona province, Italy. Neuroepidemiology 21: 74-80. doi:10.1159/000048620. PubMed: 11901276.
32. Ravaglia G, Forti P, Maioli F, Sacchetti L, Mariani E, et al. (2002) Education, occupation, and prevalence of dementia: findings from the Conselice Study. Dement Geriatr Cogn Disord 14: 90-100. doi:10.1159/000064930. PubMed: 12145456.
33. Tognoni G, Ceravolo R, Nucciarone B, Bianchi F, Dell'Agnello G, et al. (2005) From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. Acta Neurol Scand 112: 65-71. doi:10.1111/j.1600-0404.2005.00444.x. PubMed: 16008529.
34. Spada RS, Stella G, Calabrese S, Bosco P, Anello G, et al. (2009) Prevalence of dementia in mountainous village of Sicily. J Neurol Sci 283: 62-65. doi:10.1016/j.jns.2009.02.311. PubMed: 19264327.
35. Russ TC, Batty GD, Hearnshaw GF, Fenton C, Starr JM, (2012) Geographical variation in dementia: systematic review with meta-analysis. Int J Epidemiol 41: 1012-1032. doi:10.1093/ije/dys103. PubMed: 22798662.
36. Zaccai J, McCracken C, Brayne C, (2005) A systematic review of prevalence and incidence studies of dementia with Lewy bodies. Age Ageing 34: 561-566. doi:10.1093/ageing/afi190. PubMed: 16267179.
37. Aarsland D, Kurz MW, (2010) The epidemiology of dementia associated with Parkinson disease. J Neurol Sci 289: 18-22. doi:10.1016/j.jns.2009.08.034. PubMed: 19733364.
38. Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, et al. (2000) Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54: S4-S9. doi:10.1212/WNL.54.1.4. PubMed: 10854354.
39. Meulen EF, Schmand B, van Campen JP, de Koning SJ, Ponds RW, et al. (2004) The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry 75: 700-705. doi:10.1136/jnnp.2003.021055. PubMed: 15090563.
40. Knopman DS, Parisi JE, Boeve BF, Cha RH, Apaydin H, et al. (2003) Vascular dementia in a population-based autopsy study. Arch Neurol 60: 569-575. doi:10.1001/archneur.60.4.569. PubMed: 12707071.
41. European Heart Network (2012) European Cardiovascular Disease Statistics. Brussels. Available: http://www.escardio.org/about/Documents/EU-cardiovascular-disease-statistics-2012.pdf. Accessed 2 June 2013.
42. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, et al. (2013) Primary Prevention of Cardiovascular Disease with a Mediterranean Diet. N Engl J Med 368: 1279-1290. doi:10.1056/NEJMoa1200303. PubMed: 23432189.
43. Tsivgoulis G, Judd S, Letter AJ, Alexandrov AV, Howard G, et al. (2013) Adherence to a Mediterranean diet and risk of incident cognitive impairment. Neurology 80: 1684-1692. doi:10.1212/WNL.0b013e3182904f69. PubMed: 23628929.
44. Caamaño-Isorna F, Corral M, Montes-Martínez A, Takkouche B, (2006) Education and dementia: a meta-analytic study. Neuroepidemiology 26: 226-232. doi:10.1159/000093378. PubMed: 16707907.
45. Fernández Martínez M, Castro Flores J, Pérez de Las Heras S, Mandaluniz Lekumberri A, Gordejuela Menocal M, et al. (2008) Risk factors for dementia in the epidemiological study of Munguialde County (Basque Country-Spain). BMC Neurol 8: 39. doi:10.1186/1471-2377-8-39. PubMed: 18922150.
46. Fratiglioni L, Launer LJ, Andersen K, Breteler MM, Copeland JR, et al. (2000) Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology 54: S10-S15. PubMed: 10854355.
47. Helmer C, Joly P, Letenneur L, Commenges D, Dartigues JF, (2001) Mortality with dementia: results from a French prospective community-based cohort. Am J Epidemiol 154: 642-648. doi:10.1093/aje/154.7.642. PubMed: 11581098.